Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Annovis Bio (ANVS) is now available.
Annovis Bio, Inc. has successfully exercised 0.8 million warrants issued in November 2023, resulting in a capital boost of $7.0 million through the issuance of roughly the same number of common shares. The transactions, which took place between July 8 and 9, 2024, were priced at $9.00 per share. This move represents a significant financial milestone for the company, reflecting investor confidence and providing funds for future endeavors.
Find detailed analytics on ANVS stock on TipRanks’ Stock Analysis page.